SlideShare a Scribd company logo

Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies

•Download as PPT, PDF•
•
PVI, PeerView Institute for Medical Education
PVI, PeerView Institute for Medical Education

Chair and Presenters Kathleen N. Moore, MD, MS, Floor J. Backes, MD, and Bhavana Pothuri, MD, MS, discuss endometrial cancer in this CME/MOC/NCPD/AAPA/IPCE activity titled “Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/3SjJyuH. CME/MOC/NCPD/AAPA/IPCE credit will be available until April 17, 2025.

Health & Medicine
1 of 69
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies

Recommended

Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...PVI, PeerView Institute for Medical Education
 
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...PVI, PeerView Institute for Medical Education
 
On Target: Understanding the Impact of PSMA for Diagnostic and Therapeutic St...
On Target: Understanding the Impact of PSMA for Diagnostic and Therapeutic St...On Target: Understanding the Impact of PSMA for Diagnostic and Therapeutic St...
On Target: Understanding the Impact of PSMA for Diagnostic and Therapeutic St...PVI, PeerView Institute for Medical Education
 
Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...
Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...
Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...PVI, PeerView Institute for Medical Education
 
Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...
Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...
Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...PVI, PeerView Institute for Medical Education
 
Striking Back at ALL: Achieving Lasting Benefits with Bispecific Antibodies &...
Striking Back at ALL: Achieving Lasting Benefits with Bispecific Antibodies &...Striking Back at ALL: Achieving Lasting Benefits with Bispecific Antibodies &...
Striking Back at ALL: Achieving Lasting Benefits with Bispecific Antibodies &...PVI, PeerView Institute for Medical Education
 
Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...
Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...
Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...PVI, PeerView Institute for Medical Education
 
Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...
Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...
Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...PVI, PeerView Institute for Medical Education
 

Recommended

Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...PVI, PeerView Institute for Medical Education
 
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...PVI, PeerView Institute for Medical Education
 
On Target: Understanding the Impact of PSMA for Diagnostic and Therapeutic St...
On Target: Understanding the Impact of PSMA for Diagnostic and Therapeutic St...On Target: Understanding the Impact of PSMA for Diagnostic and Therapeutic St...
On Target: Understanding the Impact of PSMA for Diagnostic and Therapeutic St...PVI, PeerView Institute for Medical Education
 
Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...
Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...
Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...PVI, PeerView Institute for Medical Education
 
Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...
Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...
Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...PVI, PeerView Institute for Medical Education
 
Striking Back at ALL: Achieving Lasting Benefits with Bispecific Antibodies &...
Striking Back at ALL: Achieving Lasting Benefits with Bispecific Antibodies &...Striking Back at ALL: Achieving Lasting Benefits with Bispecific Antibodies &...
Striking Back at ALL: Achieving Lasting Benefits with Bispecific Antibodies &...PVI, PeerView Institute for Medical Education
 
Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...
Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...
Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...PVI, PeerView Institute for Medical Education
 
Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...
Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...
Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...PVI, PeerView Institute for Medical Education
 
Ten Steps for Highly Successful Myeloma Care: Guidance on the Road to Remissi...
Ten Steps for Highly Successful Myeloma Care: Guidance on the Road to Remissi...Ten Steps for Highly Successful Myeloma Care: Guidance on the Road to Remissi...
Ten Steps for Highly Successful Myeloma Care: Guidance on the Road to Remissi...PVI, PeerView Institute for Medical Education
 
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...PVI, PeerView Institute for Medical Education
 
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...PVI, PeerView Institute for Medical Education
 
Modern Team-Based Therapeutic Management for Bladder Cancer Care: Expert Stra...
Modern Team-Based Therapeutic Management for Bladder Cancer Care: Expert Stra...Modern Team-Based Therapeutic Management for Bladder Cancer Care: Expert Stra...
Modern Team-Based Therapeutic Management for Bladder Cancer Care: Expert Stra...PVI, PeerView Institute for Medical Education
 
Nurses at the Forefront of Maximizing the Potential of TROP2-Targeted Therapy...
Nurses at the Forefront of Maximizing the Potential of TROP2-Targeted Therapy...Nurses at the Forefront of Maximizing the Potential of TROP2-Targeted Therapy...
Nurses at the Forefront of Maximizing the Potential of TROP2-Targeted Therapy...PVI, PeerView Institute for Medical Education
 
BTK Inhibition Transforming the Landscape of Chronic Spontaneous Urticaria Tr...
BTK Inhibition Transforming the Landscape of Chronic Spontaneous Urticaria Tr...BTK Inhibition Transforming the Landscape of Chronic Spontaneous Urticaria Tr...
BTK Inhibition Transforming the Landscape of Chronic Spontaneous Urticaria Tr...PVI, PeerView Institute for Medical Education
 
Adapting Managed Care Strategies in the Era of Precision Medicine for Hypertr...
Adapting Managed Care Strategies in the Era of Precision Medicine for Hypertr...Adapting Managed Care Strategies in the Era of Precision Medicine for Hypertr...
Adapting Managed Care Strategies in the Era of Precision Medicine for Hypertr...PVI, PeerView Institute for Medical Education
 
Adapting Managed Care Strategies in the Era of Precision Medicine for Hypertr...
Adapting Managed Care Strategies in the Era of Precision Medicine for Hypertr...Adapting Managed Care Strategies in the Era of Precision Medicine for Hypertr...
Adapting Managed Care Strategies in the Era of Precision Medicine for Hypertr...PVI, PeerView Institute for Medical Education
 
Exploring the Evidence: Improving Cardiovascular Outcomes and the Role of Wei...
Exploring the Evidence: Improving Cardiovascular Outcomes and the Role of Wei...Exploring the Evidence: Improving Cardiovascular Outcomes and the Role of Wei...
Exploring the Evidence: Improving Cardiovascular Outcomes and the Role of Wei...PVI, PeerView Institute for Medical Education
 
Interdisciplinary Approaches to Management of Immune-Mediated Inflammatory Di...
Interdisciplinary Approaches to Management of Immune-Mediated Inflammatory Di...Interdisciplinary Approaches to Management of Immune-Mediated Inflammatory Di...
Interdisciplinary Approaches to Management of Immune-Mediated Inflammatory Di...PVI, PeerView Institute for Medical Education
 
Treatment Advances and Individualized Therapeutic Strategies in Prostate Canc...
Treatment Advances and Individualized Therapeutic Strategies in Prostate Canc...Treatment Advances and Individualized Therapeutic Strategies in Prostate Canc...
Treatment Advances and Individualized Therapeutic Strategies in Prostate Canc...PVI, PeerView Institute for Medical Education
 
Charting a New Path to Better Outcomes With TROP2-Targeting ADCs in Lung Canc...
Charting a New Path to Better Outcomes With TROP2-Targeting ADCs in Lung Canc...Charting a New Path to Better Outcomes With TROP2-Targeting ADCs in Lung Canc...
Charting a New Path to Better Outcomes With TROP2-Targeting ADCs in Lung Canc...PVI, PeerView Institute for Medical Education
 
Biologics in CRSwNP: Putting a Paradigm Shift Into Practice
Biologics in CRSwNP: Putting a Paradigm Shift Into PracticeBiologics in CRSwNP: Putting a Paradigm Shift Into Practice
Biologics in CRSwNP: Putting a Paradigm Shift Into PracticePVI, PeerView Institute for Medical Education
 
Biologics in CRSwNP: Putting a Paradigm Shift Into Practice
Biologics in CRSwNP: Putting a Paradigm Shift Into PracticeBiologics in CRSwNP: Putting a Paradigm Shift Into Practice
Biologics in CRSwNP: Putting a Paradigm Shift Into PracticePVI, PeerView Institute for Medical Education
 
Prescriptions for Successful Myeloma Care: Pharmacy Strategies for Delivering...
Prescriptions for Successful Myeloma Care: Pharmacy Strategies for Delivering...Prescriptions for Successful Myeloma Care: Pharmacy Strategies for Delivering...
Prescriptions for Successful Myeloma Care: Pharmacy Strategies for Delivering...PVI, PeerView Institute for Medical Education
 
Precision & Progress Against NF1: Solutions for Better Outcomes With MEKi & M...
Precision & Progress Against NF1: Solutions for Better Outcomes With MEKi & M...Precision & Progress Against NF1: Solutions for Better Outcomes With MEKi & M...
Precision & Progress Against NF1: Solutions for Better Outcomes With MEKi & M...PVI, PeerView Institute for Medical Education
 
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Po...
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Po...Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Po...
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Po...PVI, PeerView Institute for Medical Education
 
Advancing ADCs in Gynecologic Cancers: Expert Insights on Recent Evidence, Im...
Advancing ADCs in Gynecologic Cancers: Expert Insights on Recent Evidence, Im...Advancing ADCs in Gynecologic Cancers: Expert Insights on Recent Evidence, Im...
Advancing ADCs in Gynecologic Cancers: Expert Insights on Recent Evidence, Im...PVI, PeerView Institute for Medical Education
 
Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...
Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...
Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...PVI, PeerView Institute for Medical Education
 
Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...
Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...
Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...PVI, PeerView Institute for Medical Education
 
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHYTUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHYDRPREETHIJAMESP
 
180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghanahealthwatchghana
 

More Related Content

More from PVI, PeerView Institute for Medical Education

More from PVI, PeerView Institute for Medical Education (20)

Ten Steps for Highly Successful Myeloma Care: Guidance on the Road to Remissi...
Ten Steps for Highly Successful Myeloma Care: Guidance on the Road to Remissi...Ten Steps for Highly Successful Myeloma Care: Guidance on the Road to Remissi...
Ten Steps for Highly Successful Myeloma Care: Guidance on the Road to Remissi...
 
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
 
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
 
Modern Team-Based Therapeutic Management for Bladder Cancer Care: Expert Stra...
Modern Team-Based Therapeutic Management for Bladder Cancer Care: Expert Stra...Modern Team-Based Therapeutic Management for Bladder Cancer Care: Expert Stra...
Modern Team-Based Therapeutic Management for Bladder Cancer Care: Expert Stra...
 
Nurses at the Forefront of Maximizing the Potential of TROP2-Targeted Therapy...
Nurses at the Forefront of Maximizing the Potential of TROP2-Targeted Therapy...Nurses at the Forefront of Maximizing the Potential of TROP2-Targeted Therapy...
Nurses at the Forefront of Maximizing the Potential of TROP2-Targeted Therapy...
 
BTK Inhibition Transforming the Landscape of Chronic Spontaneous Urticaria Tr...
BTK Inhibition Transforming the Landscape of Chronic Spontaneous Urticaria Tr...BTK Inhibition Transforming the Landscape of Chronic Spontaneous Urticaria Tr...
BTK Inhibition Transforming the Landscape of Chronic Spontaneous Urticaria Tr...
 
Adapting Managed Care Strategies in the Era of Precision Medicine for Hypertr...
Adapting Managed Care Strategies in the Era of Precision Medicine for Hypertr...Adapting Managed Care Strategies in the Era of Precision Medicine for Hypertr...
Adapting Managed Care Strategies in the Era of Precision Medicine for Hypertr...
 
Adapting Managed Care Strategies in the Era of Precision Medicine for Hypertr...
Adapting Managed Care Strategies in the Era of Precision Medicine for Hypertr...Adapting Managed Care Strategies in the Era of Precision Medicine for Hypertr...
Adapting Managed Care Strategies in the Era of Precision Medicine for Hypertr...
 
Exploring the Evidence: Improving Cardiovascular Outcomes and the Role of Wei...
Exploring the Evidence: Improving Cardiovascular Outcomes and the Role of Wei...Exploring the Evidence: Improving Cardiovascular Outcomes and the Role of Wei...
Exploring the Evidence: Improving Cardiovascular Outcomes and the Role of Wei...
 
Interdisciplinary Approaches to Management of Immune-Mediated Inflammatory Di...
Interdisciplinary Approaches to Management of Immune-Mediated Inflammatory Di...Interdisciplinary Approaches to Management of Immune-Mediated Inflammatory Di...
Interdisciplinary Approaches to Management of Immune-Mediated Inflammatory Di...
 
Treatment Advances and Individualized Therapeutic Strategies in Prostate Canc...
Treatment Advances and Individualized Therapeutic Strategies in Prostate Canc...Treatment Advances and Individualized Therapeutic Strategies in Prostate Canc...
Treatment Advances and Individualized Therapeutic Strategies in Prostate Canc...
 
Charting a New Path to Better Outcomes With TROP2-Targeting ADCs in Lung Canc...
Charting a New Path to Better Outcomes With TROP2-Targeting ADCs in Lung Canc...Charting a New Path to Better Outcomes With TROP2-Targeting ADCs in Lung Canc...
Charting a New Path to Better Outcomes With TROP2-Targeting ADCs in Lung Canc...
 
Biologics in CRSwNP: Putting a Paradigm Shift Into Practice
Biologics in CRSwNP: Putting a Paradigm Shift Into PracticeBiologics in CRSwNP: Putting a Paradigm Shift Into Practice
Biologics in CRSwNP: Putting a Paradigm Shift Into Practice
 
Biologics in CRSwNP: Putting a Paradigm Shift Into Practice
Biologics in CRSwNP: Putting a Paradigm Shift Into PracticeBiologics in CRSwNP: Putting a Paradigm Shift Into Practice
Biologics in CRSwNP: Putting a Paradigm Shift Into Practice
 
Prescriptions for Successful Myeloma Care: Pharmacy Strategies for Delivering...
Prescriptions for Successful Myeloma Care: Pharmacy Strategies for Delivering...Prescriptions for Successful Myeloma Care: Pharmacy Strategies for Delivering...
Prescriptions for Successful Myeloma Care: Pharmacy Strategies for Delivering...
 
Precision & Progress Against NF1: Solutions for Better Outcomes With MEKi & M...
Precision & Progress Against NF1: Solutions for Better Outcomes With MEKi & M...Precision & Progress Against NF1: Solutions for Better Outcomes With MEKi & M...
Precision & Progress Against NF1: Solutions for Better Outcomes With MEKi & M...
 
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Po...
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Po...Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Po...
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Po...
 
Advancing ADCs in Gynecologic Cancers: Expert Insights on Recent Evidence, Im...
Advancing ADCs in Gynecologic Cancers: Expert Insights on Recent Evidence, Im...Advancing ADCs in Gynecologic Cancers: Expert Insights on Recent Evidence, Im...
Advancing ADCs in Gynecologic Cancers: Expert Insights on Recent Evidence, Im...
 
Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...
Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...
Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...
 
Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...
Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...
Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...
 

Recently uploaded

TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHYTUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHYDRPREETHIJAMESP
 
180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghanahealthwatchghana
 
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDr.shiva sai vemula
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMeenakshiGursamy
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadNephroTube - Dr.Gawad
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Catherine Liao
 
Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.Anjali Parmar
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationMedicoseAcademics
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxdrtabassum4
 
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالةGallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالةMohamad محمد Al-Gailani الكيلاني
 
Factors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryFactors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryDr Simran Deepak Vangani
 
Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)Cancer Institute NSW
 
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptxSURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptxSuresh Kumar K
 
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartMedicoseAcademics
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...Ayman Seddik
 
Video capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenVideo capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenRaju678948
 
Effects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthEffects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthCatherine Liao
 
In-service education (Nursing Mangement)
In-service education (Nursing Mangement)In-service education (Nursing Mangement)
In-service education (Nursing Mangement)Monika Kanwar
 
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale nowSherrylee83
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAkashGanganePatil1
 

Recently uploaded (20)

TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHYTUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
 
180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana
 
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of action
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptx
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...
 
Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالةGallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
 
Factors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryFactors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric Dentistry
 
Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)
 
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptxSURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
 
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
 
Video capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenVideo capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in children
 
Effects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthEffects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial health
 
In-service education (Nursing Mangement)
In-service education (Nursing Mangement)In-service education (Nursing Mangement)
In-service education (Nursing Mangement)
 
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT